Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...

Join our API course for an in-depth understanding of active pharmaceutical ingredients in drug manufacturing. Learn the regulatory frameworks of the EU and USA, GMP and GDP practices, and key ...

French biotech MaaT Pharma has signed a licensing and distribution agreement with UK-based Clinigen, positioning the company ...

A new European Commission strategy promises to lift life sciences in the region out of a two-decade slump by tackling ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a ...

The server encountered an error and could not complete your request. If the problem persists, please contact us using the ...

Altogether, the “pharma package,” issued in the form of a directive and a regulation, represents “the biggest reform to EU’s laws on medicines in over two decades,” according to the Council.

The pharma package The proposals for a regulation and directive that make up the so-called ‘pharma’ package constitute the biggest reform to the EU’s laws on medicines in over two decades. They aim to ...

Many European pharma companies are taking steps to proactively counter the threats of US tariffs. These measures include challenging their material supply chains, questioning whether the US remains ...

Explore the 1,2-Hexanediol market’s growth in cosmetics, pharma, and industrial uses, driven by sustainability, bio-based ...